Articoli di riviste sul tema "Reverse docking"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Reverse docking".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Soto Zuluaga, Juan Pablo, Marcus Thiell e Rosa Colomé Perales. "Reverse cross-docking". Omega 66 (gennaio 2017): 48–57. http://dx.doi.org/10.1016/j.omega.2016.01.010.
Testo completoListyani, Tiara Ajeng, e Rina Herowati. "Analisis Docking Molekuler Senyawa Derivat Phthalimide sebagai Inhibitor Non-Nukleosida HIV-1 Reverse Transcriptase". Jurnal Farmasi Indonesia 15, n. 2 (1 novembre 2018): 123–34. http://dx.doi.org/10.31001/jfi.v15i2.445.
Testo completoSeal, Abhik, Riju Aykkal e Mriganka Ghosh Ghosh. "Docking study of HIV-1 reverse transcriptase with phytochemicals". Bioinformation 5, n. 10 (15 febbraio 2011): 430–39. http://dx.doi.org/10.6026/97320630005430.
Testo completoPark, Kichul, e Art E. Cho. "Using reverse docking to identify potential targets for ginsenosides". Journal of Ginseng Research 41, n. 4 (ottobre 2017): 534–39. http://dx.doi.org/10.1016/j.jgr.2016.10.005.
Testo completoDA SILVA, CARLOS H. T. P., IVONE CARVALHO e CARLTON A. TAFT. "MOLECULAR DYNAMICS, DOCKING, DENSITY FUNCTIONAL, AND ADMET STUDIES OF HIV-1 REVERSE TRANSCRIPTASE INHIBITORS". Journal of Theoretical and Computational Chemistry 05, n. 03 (settembre 2006): 579–86. http://dx.doi.org/10.1142/s0219633606002441.
Testo completoResti, Lady Ichwana, Herman Mawengkang e Elly Rosmaini. "Mathematical Model for Vehicle Routing and Scheduling with Forward and Reverse Logistics". Sinkron 8, n. 3 (1 luglio 2023): 1536–43. http://dx.doi.org/10.33395/sinkron.v8i3.12599.
Testo completoWang, Yan, Aidong Wang, Jianhua Wang, Xiaoran Wu, Yijie Sun e Yan Wu. "Me-Better Drug Design Based on Nevirapine and Mechanism of Molecular Interactions with Y188C Mutant HIV-1 Reverse Transcriptase". Molecules 27, n. 21 (29 ottobre 2022): 7348. http://dx.doi.org/10.3390/molecules27217348.
Testo completoByler, Kendall, e William Setzer. "Protein Targets of Frankincense: A Reverse Docking Analysis of Terpenoids from Boswellia Oleo-Gum Resins". Medicines 5, n. 3 (31 agosto 2018): 96. http://dx.doi.org/10.3390/medicines5030096.
Testo completoRuswanto, Ruswanto, Richa Mardianingrum, Siswandono Siswandono e Dini Kesuma. "Reverse Docking, Molecular Docking, Absorption, Distribution, and Toxicity Prediction of Artemisinin as an Anti-diabetic Candidate". Molekul 15, n. 2 (27 luglio 2020): 88. http://dx.doi.org/10.20884/1.jm.2020.15.2.579.
Testo completoRiza, Hafrizal, Andhi Fahrurroji, Arif Wicaksono, Ahmad Kharis Nugroho e Sudibyo Martono. "DOCKING STUDY OF METHYL HESPERIDIN AS NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR". International Journal of Pharmacy and Pharmaceutical Sciences 10, n. 3 (1 marzo 2018): 85. http://dx.doi.org/10.22159/ijpps.2018v10i3.22724.
Testo completo., T. B. Kakade. "Homology Modeling and Docking Studies on HIV Reverse Transcriptase Inhibitors". Journal of Current Pharma Research 3, n. 3 (15 maggio 2013): 965–82. http://dx.doi.org/10.33786/jcpr.2013.v03i03.010.
Testo completoSaleem, Mehmood, Mehar, Khan, Khan, Ashraf, Ali et al. "Bioassay Directed Isolation, Biological Evaluation and in Silico Studies of New Isolates from Pteris cretica L." Antioxidants 8, n. 7 (19 luglio 2019): 231. http://dx.doi.org/10.3390/antiox8070231.
Testo completoIksan, Muhamad, Frida M. Yusuf, Fitriani Fitriani B e Wa Ode Al Zarliani. "Antipyretic Drug Candidates Through Reverse Docking Techniques Used In Science Learning". Jurnal Penelitian Pendidikan IPA 9, n. 8 (25 agosto 2023): 6398–405. http://dx.doi.org/10.29303/jppipa.v9i8.4863.
Testo completoTong, Jianbo, Shan Lei, Pei Zhan, Shangshang Qin e Yang Wang. "QSAR and Docking Studies of DATA Analogues as HIV-1 Reverse Transcriptase Inhibitors". Letters in Drug Design & Discovery 16, n. 2 (29 novembre 2018): 153–59. http://dx.doi.org/10.2174/1570180815666180413152636.
Testo completoSavita, Mahendra Kumar, Neha Bora, Ruby Singh e Prachi Srivastava. "Screening of camphene as a potential inhibitor targeting SARS-CoV-2 various structural and functional mutants: Through reverse docking approach". Environmental Health Engineering and Management 10, n. 2 (27 maggio 2023): 123–29. http://dx.doi.org/10.34172/ehem.2023.14.
Testo completoDarme, Pierre, Manuel Dauchez, Arnaud Renard, Laurence Voutquenne-Nazabadioko, Dominique Aubert, Sandie Escotte-Binet, Jean-Hugues Renault, Isabelle Villena, Luiz-Angelo Steffenel e Stéphanie Baud. "AMIDE v2: High-Throughput Screening Based on AutoDock-GPU and Improved Workflow Leading to Better Performance and Reliability". International Journal of Molecular Sciences 22, n. 14 (13 luglio 2021): 7489. http://dx.doi.org/10.3390/ijms22147489.
Testo completoKotadiya, Manisha, e Ravi Ajudia. "In-silico Docking and ADME Studies of Natural Phytoconstituents from Different Medicinal Plants as Potential HIV Reverse Transcriptase Inhibitors". INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE 15, n. 01 (25 marzo 2024): 115–18. http://dx.doi.org/10.25258/ijpqa.15.1.18.
Testo completoKharkar, Prashant S., Sona Warrier e Ram S. Gaud. "Reverse docking: a powerful tool for drug repositioning and drug rescue". Future Medicinal Chemistry 6, n. 3 (marzo 2014): 333–42. http://dx.doi.org/10.4155/fmc.13.207.
Testo completoKawsar, Sarkar Mohammad Abe, Mohammed Anowar Hosen, Tasneem Sultana Chowdhury, Kazi Masud Rana, Yuki Fujii e Yasuhiro Ozeki. "Thermochemical, PASS, Molecular Docking, Drug-Likeness and In Silico ADMET Prediction of Cytidine Derivatives against HIV-1 Reverse Transcriptase". Revista de Chimie 72, n. 3 (29 luglio 2021): 159–78. http://dx.doi.org/10.37358/rc.21.3.8446.
Testo completoEarlia, Nanda, Muslem, Rivansyah Suhendra, Mohamad Amin, C. R. S. Prakoeswa, Khairan e Rinaldi Idroes. "GC/MS Analysis of Fatty Acids on Pliek U Oil and Its Pharmacological Study by Molecular Docking to Filaggrin as a Drug Candidate in Atopic Dermatitis Treatment". Scientific World Journal 2019 (3 novembre 2019): 1–7. http://dx.doi.org/10.1155/2019/8605743.
Testo completoAldholmi, Mohammed, Rizwan Ahmad, Mohammad Habeeb Shaikh, Ayad Mohammed Salem, Maher Alqurashi e Mansour Alturki. "Anti-Infective Activity of Momordica charantia Extract with Molecular Docking of Its Triterpenoid Glycosides". Antibiotics 13, n. 6 (11 giugno 2024): 544. http://dx.doi.org/10.3390/antibiotics13060544.
Testo completoHarriman, D. Joseph, e Ghislain Deslongchamps. "Reverse-docking as a computational tool for the study of asymmetric organocatalysis". Journal of Computer-Aided Molecular Design 18, n. 5 (maggio 2004): 303–8. http://dx.doi.org/10.1023/b:jcam.0000047813.47656.36.
Testo completoZhang, Haiping, Jianbo Pan, Xuli Wu, Ai-Ren Zuo, Yanjie Wei e Zhi-Liang Ji. "Large-Scale Target Identification of Herbal Medicine Using a Reverse Docking Approach". ACS Omega 4, n. 6 (4 giugno 2019): 9710–19. http://dx.doi.org/10.1021/acsomega.9b00020.
Testo completoHarriman, D. Joseph, e Ghislain Deslongchamps. "Reverse-docking study of the TADDOL-catalyzed asymmetric hetero-Diels–Alder reaction". Journal of Molecular Modeling 12, n. 6 (23 febbraio 2006): 793–97. http://dx.doi.org/10.1007/s00894-006-0097-z.
Testo completoLee, Aeri, Kyoungyeul Lee e Dongsup Kim. "Using reverse docking for target identification and its applications for drug discovery". Expert Opinion on Drug Discovery 11, n. 7 (giugno 2016): 707–15. http://dx.doi.org/10.1080/17460441.2016.1190706.
Testo completoChandra, Priyanka, Swastika Ganguly e Soikata Karmakar. "Comparative Studies of Various NNRTIs in the Active Site of Different HIV-1RT Receptors". Chemistry Proceedings 3, n. 1 (14 novembre 2020): 33. http://dx.doi.org/10.3390/ecsoc-24-08313.
Testo completoK., Sony Jacob, e Swastika Ganguly. "A BATTLE AGAINST AIDS: NEW PYRAZOLE KEY TO AN OLDER LOCK-REVERSE TRANSCRIPTASE". International Journal of Pharmacy and Pharmaceutical Sciences 8, n. 11 (28 ottobre 2016): 75. http://dx.doi.org/10.22159/ijpps.2016v8i11.12634.
Testo completoTshering, Kipchu, e Mir Misbahuddin. "In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer". Bangabandhu Sheikh Mujib Medical University Journal 9, n. 3 (21 settembre 2016): 164. http://dx.doi.org/10.3329/bsmmuj.v9i3.29650.
Testo completoWang, Junmei, Xinshan Kang, Irwin D. Kuntz e Peter A. Kollman. "Hierarchical Database Screenings for HIV-1 Reverse Transcriptase Using a Pharmacophore Model, Rigid Docking, Solvation Docking, and MM−PB/SA". Journal of Medicinal Chemistry 48, n. 7 (aprile 2005): 2432–44. http://dx.doi.org/10.1021/jm049606e.
Testo completoNugraha, Rivo YB, Icha FD Faratisha, Kana Mardhiyyah, Dio G. Ariel, Fitria F. Putri, Nafisatuzzamrudah, Sri Winarsih, Teguh W. Sardjono e Loeki E. Fitri. "Antimalarial Properties of Isoquinoline Derivative from Streptomyces hygroscopicus subsp. Hygroscopicus: An In Silico Approach". BioMed Research International 2020 (9 gennaio 2020): 1–15. http://dx.doi.org/10.1155/2020/6135696.
Testo completoTien, Nguyen Truong, e Bui Tho Thanh. "Predicting binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase using molecular docking". Science and Technology Development Journal - Natural Sciences 2, n. 1 (6 gennaio 2019): 53–58. http://dx.doi.org/10.32508/stdjns.v2i1.674.
Testo completoKhan, Mahmood-ul-Hassan, Shahid Hameed, Muhammad Farman, Najim A. Al-Masoudi e Helen Stoeckli-Evans. "Synthesis, anti-HIV activity and molecular modeling study of 3-aryl-6-adamantylmethyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives". Zeitschrift für Naturforschung B 70, n. 8 (1 agosto 2015): 609–16. http://dx.doi.org/10.1515/znb-2015-0032.
Testo completoKonyar, Dilan, e Muhammed Tılahun Muhammed. "MOLECULAR DOCKING AND MOLECULAR DYNAMICS SIMULATIONS INHIBITION AGAINST OF HUMAN TELOMERASE BY NUCLEOSIDE AND NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIs/NNRTIs)". Ankara Universitesi Eczacilik Fakultesi Dergisi 48, n. 2 (17 aprile 2024): 18. http://dx.doi.org/10.33483/jfpau.1444259.
Testo completoTarasova, Olga, Vladimir Poroikov e Alexander Veselovsky. "Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review". Molecules 23, n. 5 (21 maggio 2018): 1233. http://dx.doi.org/10.3390/molecules23051233.
Testo completoFan, Shengjun, Qiang Geng, Zhenyu Pan, Xin Li, Lu Tie, Yan Pan e Xuejun Li. "Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach". BMC Systems Biology 6, n. 1 (2012): 152. http://dx.doi.org/10.1186/1752-0509-6-152.
Testo completoBillones, Junie. "Reverse docking study unravels the potential Mycobacterium tuberculosis enzyme targets of Agelasine F". Oriental Journal of Chemistry 32, n. 2 (25 aprile 2016): 851–58. http://dx.doi.org/10.13005/ojc/320210.
Testo completoJoseph Harriman, D., Glen F. Deleavey, Andreas Lambropoulos e Ghislain Deslongchamps. "Reverse-docking study of the organocatalyzed asymmetric Strecker hydrocyanation of aldimines and ketimines". Tetrahedron 63, n. 52 (dicembre 2007): 13032–38. http://dx.doi.org/10.1016/j.tet.2007.10.009.
Testo completoRagno, Rino, Simona Frasca, Fabrizio Manetti, Antonella Brizzi e Silvio Massa. "HIV-Reverse Transcriptase Inhibition: Inclusion of Ligand-Induced Fit by Cross-Docking Studies". Journal of Medicinal Chemistry 48, n. 1 (gennaio 2005): 200–212. http://dx.doi.org/10.1021/jm0493921.
Testo completoKheirkhah, Amirsaman, e Saeid Rezaei. "Using cross-docking operations in a reverse logistics network design: a new approach". Production Engineering 10, n. 2 (28 novembre 2015): 175–84. http://dx.doi.org/10.1007/s11740-015-0646-3.
Testo completoPitta, Eleni, Evangelia Tsolaki, Athina Geronikaki, Jovana Petrović, Jasmina Glamočlija, Marina Soković, Emmanuele Crespan, Giovanni Maga, Shome S. Bhunia e Anil K. Saxena. "4-Thiazolidinone derivatives as potent antimicrobial agents: microwave-assisted synthesis, biological evaluation and docking studies". MedChemComm 6, n. 2 (2015): 319–26. http://dx.doi.org/10.1039/c4md00399c.
Testo completoAlharbi, Ahmed. "Molecular docking based design of Inhibitors for viral Non-Nucleosidase as potential anti-retroviral agents". Bioinformation 16, n. 10 (31 ottobre 2020): 736–41. http://dx.doi.org/10.6026/97320630016736.
Testo completoGong, Chang, Zihao Liu, Qun Lin, Yu Shi, Qing Luo, Yinghuan Cen, Juanmei Li, Xiaolin Fang e Wenguo Jiang. "Anti-PITPNM3 small molecular compounds reverse breast cancer metastasis by targeting PITPNM3." Journal of Clinical Oncology 39, n. 15_suppl (20 maggio 2021): e15005-e15005. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e15005.
Testo completoChandra, Priyanka, Swastika Swastika e Manik Ghosh. "In Silico Studies of Piperazinyl-4-Nitroimidazole Derivatives in the Non-Nucleoside Inhibitory Binding Pocket of Human Immunodeficiency Virus-1-Reverse Transcriptase Enzyme". INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY 33, n. 03 (30 settembre 2023): 293. http://dx.doi.org/10.59467/ijhc.2023.33.293.
Testo completoKrishnamoorthy, Praveen K. P., Sekar Subasree, Udhayachandran Arthi, Mohammad Mobashir, Chirag Gowda e Prasanna D. Revanasiddappa. "T-cell Epitope-based Vaccine Design for Nipah Virus by Reverse Vaccinology Approach". Combinatorial Chemistry & High Throughput Screening 23, n. 8 (2 novembre 2020): 788–96. http://dx.doi.org/10.2174/1386207323666200427114343.
Testo completoRasyadan Taufiq Probojati, Ahmad Affan Ali Murtadlo, Md. Emdad Ullah, Sin War Naw e Dora Dayu Rahma Turista. "Molecular Docking Study of HIV-1 Antiretroviral Candidate via Reverse Transcriptase Inhibitor from Zingiber officinale var. Roscoe". SAINSTEK International Journal on Applied Science, Advanced Technology and Informatics 1, n. 01 (9 giugno 2022): 26–31. http://dx.doi.org/10.24036/sainstek/vol1-iss01/6.
Testo completoWang, Yueping, Jie Chang, Jiangyuan Wang, Peng Zhong, Yufang Zhang, Christopher Cong Lai e Yanping He. "3D-QSAR Studies of S-DABO Derivatives as Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors". Letters in Drug Design & Discovery 16, n. 8 (8 agosto 2019): 868–81. http://dx.doi.org/10.2174/1570180815666180810112321.
Testo completoMukherjee, Taniya, Isha Sangal, Biswajit Sarkar, Qais Almaamari e Tamer M. Alkadash. "How Effective Is Reverse Cross-Docking and Carbon Policies in Controlling Carbon Emission from the Fashion Industry?" Mathematics 11, n. 13 (27 giugno 2023): 2880. http://dx.doi.org/10.3390/math11132880.
Testo completoRotich, Winnie, Nicholas J. Sadgrove, Eduard Mas-Claret, Guillermo F. Padilla-González, Anastasia Guantai e Moses K. Langat. "HIV-1 Reverse Transcriptase Inhibition by Major Compounds in a Kenyan Multi-Herbal Composition (CareVid™): In Vitro and In Silico Contrast". Pharmaceuticals 14, n. 10 (30 settembre 2021): 1009. http://dx.doi.org/10.3390/ph14101009.
Testo completoIslam, Sk Injamamul, Saloa Sanjida, Sheikh Sunzid Ahmed, Mazen Almehmadi, Mamdouh Allahyani, Abdulelah Aljuaid, Ahad Amer Alsaiari e Mustafa Halawi. "Core Proteomics and Immunoinformatic Approaches to Design a Multiepitope Reverse Vaccine Candidate against Chagas Disease". Vaccines 10, n. 10 (7 ottobre 2022): 1669. http://dx.doi.org/10.3390/vaccines10101669.
Testo completoSree Latha, Ramaswamy, Ramadoss Vijayaraj, Ettayapuram Ramaprasad Azhagiya Singam, Krishnaswamy Chitra e Venkatesan Subramanian. "3D-QSAR and Docking Studies on the HEPT Derivatives of HIV-1 Reverse Transcriptase". Chemical Biology & Drug Design 78, n. 3 (29 luglio 2011): 418–26. http://dx.doi.org/10.1111/j.1747-0285.2011.01162.x.
Testo completo